Back to search
KCNT1-Related Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which KCNT1-Related Epilepsy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which KCNT1-Related Epilepsy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Study CL1-230815-001 (KANDLE) is a Phase Ib/II, First In Human, multicentre, open-label, multiple ascending dose study to assess the safety, tolerability, pharm…
This trial will evaluate the safety, tolerability, pharmacokinetics, and clinical activity of ABS-1230 compared with placebo in participants with KCNT1-related…
This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted d…